Business Description
Fresenius Medical Care AG
NAICS : 621492
SIC : 8092
ISIN : DE0005785802
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.89 | |||||
Debt-to-EBITDA | 3.75 | |||||
Interest Coverage | 3.61 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.62 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3 | |||||
3-Year EBITDA Growth Rate | -8 | |||||
3-Year EPS without NRI Growth Rate | -17.1 | |||||
3-Year FCF Growth Rate | -15.1 | |||||
3-Year Book Growth Rate | 6.6 | |||||
Future 3-5Y EPS without NRI Growth Rate | 12.15 | |||||
Future 3-5Y Total Revenue Growth Rate | 2.8 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 72.06 | |||||
9-Day RSI | 70.23 | |||||
14-Day RSI | 65.36 | |||||
6-1 Month Momentum % | 5.74 | |||||
12-1 Month Momentum % | -16.78 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.42 | |||||
Quick Ratio | 1.07 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 57.49 | |||||
Days Sales Outstanding | 70.31 | |||||
Days Payable | 22.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.87 | |||||
Dividend Payout Ratio | 0.61 | |||||
3-Year Dividend Growth Rate | -2.3 | |||||
Forward Dividend Yield % | 3.05 | |||||
5-Year Yield-on-Cost % | 3.16 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 8.55 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 25.32 | |||||
Operating Margin % | 7.89 | |||||
Net Margin % | 2.57 | |||||
FCF Margin % | 9.99 | |||||
ROE % | 3.62 | |||||
ROA % | 1.42 | |||||
ROIC % | 3.35 | |||||
ROC (Joel Greenblatt) % | 13.95 | |||||
ROCE % | 5.08 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.92 | |||||
Forward PE Ratio | 12 | |||||
PE Ratio without NRI | 21.17 | |||||
Shiller PE Ratio | 9.37 | |||||
Price-to-Owner-Earnings | 6 | |||||
PS Ratio | 0.59 | |||||
PB Ratio | 0.84 | |||||
Price-to-Free-Cash-Flow | 5.88 | |||||
Price-to-Operating-Cash-Flow | 4.35 | |||||
EV-to-EBIT | 15.05 | |||||
EV-to-Forward-EBIT | 11.96 | |||||
EV-to-EBITDA | 6.84 | |||||
EV-to-Forward-EBITDA | 6.87 | |||||
EV-to-Revenue | 1.13 | |||||
EV-to-Forward-Revenue | 1.1 | |||||
EV-to-FCF | 11.29 | |||||
Price-to-Projected-FCF | 0.42 | |||||
Price-to-Median-PS-Value | 0.46 | |||||
Earnings Yield (Greenblatt) % | 6.64 | |||||
FCF Yield % | 17.01 | |||||
Forward Rate of Return (Yacktman) % | 12.61 |